Why this US health insurance stock is being mispriced

There is a US healthcare stock that has consistently delivered in terms of growth, but has been largely unappreciated by the market. Despite producing large amounts of cash flow, it has recently seen its share price fall roughly 40%. However, the reasons behind this slump are purely political and shouldn't detract from the true returns that the business is able to offer investors.

Jordan Cvetanovski, Portfolio Manager, Pengana International Equities, explains how, in spite of the sector taking a hit after the ‘Medicare for All’ policy was thrust in front of US voters by presidential hopeful Bernie Sanders, there is still value to be found among US health insurers due to the mispricing of political risk.

Watch the exclusive video below where Jordan outlines the investment thesis behind one of Pengana's more controversial stock picks.

Access growing companies at compelling valuations

Jordan aims to provide exposure to a diversified portfolio of highly cash-generative and growing global companies purchased at compelling valuations. The portfolio is created from the 30-50 stock ideas that work best together, rather than just the 30-50 best ideas. To find out more click 'contact' below.